These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36389737)

  • 1. Modulating the microenvironment during FVIII uptake influences the nature of FVIII-peptides presented by antigen-presenting cells.
    Lubich C; Steinitz KN; Hoelbl B; Prenninger T; van Helden PM; Weiller M; Reipert BM
    Front Immunol; 2022; 13():975680. PubMed ID: 36389737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD4+ T-cell epitopes associated with antibody responses after intravenously and subcutaneously applied human FVIII in humanized hemophilic E17 HLA-DRB1*1501 mice.
    Steinitz KN; van Helden PM; Binder B; Wraith DC; Unterthurner S; Hermann C; Schuster M; Ahmad RU; Weiller M; Lubich C; de la Rosa M; Schwarz HP; Reipert BM
    Blood; 2012 Apr; 119(17):4073-82. PubMed ID: 22394599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hunting down factor VIII in the immunopeptidome.
    Hartholt RB; Peyron I; Voorberg J
    Cell Immunol; 2016 Mar; 301():59-64. PubMed ID: 26610639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dangerous liaisons: how the immune system deals with factor VIII.
    Wroblewska A; Reipert BM; Pratt KP; Voorberg J
    J Thromb Haemost; 2013 Jan; 11(1):47-55. PubMed ID: 23140211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4+ T-cell clones specific for wild-type factor VIII: a molecular mechanism responsible for a higher incidence of inhibitor formation in mild/moderate hemophilia A.
    Jacquemin M; Vantomme V; Buhot C; Lavend'homme R; Burny W; Demotte N; Chaux P; Peerlinck K; Vermylen J; Maillere B; van der Bruggen P; Saint-Remy JM
    Blood; 2003 Feb; 101(4):1351-8. PubMed ID: 12393451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limited promiscuity of HLA-DRB1 presented peptides derived of blood coagulation factor VIII.
    van Haren SD; Wroblewska A; Herczenik E; Kaijen PH; Ruminska A; ten Brinke A; Meijer AB; Voorberg J
    PLoS One; 2013; 8(11):e80239. PubMed ID: 24244658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Requirements for immune recognition and processing of factor VIII by antigen-presenting cells.
    van Haren SD; Wroblewska A; Fischer K; Voorberg J; Herczenik E
    Blood Rev; 2012 Jan; 26(1):43-9. PubMed ID: 22036515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor VIII inhibitors: role of von Willebrand factor on the uptake of factor VIII by dendritic cells.
    Kaveri SV; Dasgupta S; Andre S; Navarrete AM; Repessé Y; Wootla B; Lacroix-Desmazes S
    Haemophilia; 2007 Dec; 13 Suppl 5():61-4. PubMed ID: 18078399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-DR-presented peptide repertoires derived from human monocyte-derived dendritic cells pulsed with blood coagulation factor VIII.
    van Haren SD; Herczenik E; ten Brinke A; Mertens K; Voorberg J; Meijer AB
    Mol Cell Proteomics; 2011 Jun; 10(6):M110.002246. PubMed ID: 21467215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerating Factor VIII: Recent Progress.
    Lacroix-Desmazes S; Voorberg J; Lillicrap D; Scott DW; Pratt KP
    Front Immunol; 2019; 10():2991. PubMed ID: 31998296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralizing Antibodies Against Factor VIII Can Occur Through a Non-Germinal Center Pathway.
    Patel SR; Lundgren TS; Baldwin WH; Cox C; Parker ET; Healey JF; Jajosky RP; Zerra PE; Josephson CD; Doering CB; Stowell SR; Meeks SL
    Front Immunol; 2022; 13():880829. PubMed ID: 35634288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human CD4+ T-cell epitope repertoire on the C2 domain of coagulation factor VIII.
    Reding MT; Okita DK; Diethelm-Okita BM; Anderson TA; Conti-Fine BM
    J Thromb Haemost; 2003 Aug; 1(8):1777-84. PubMed ID: 12911593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of activated T follicular helper cells is critical for anti-FVIII inhibitor development in hemophilia A mice.
    Jing W; Chen J; Cai Y; Chen Y; Schroeder JA; Johnson BD; Cui W; Shi Q
    Blood Adv; 2019 Oct; 3(20):3099-3110. PubMed ID: 31648333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of an exposed loop in the C1 domain reduces immune responses to factor VIII in hemophilia A mice.
    Wroblewska A; van Haren SD; Herczenik E; Kaijen P; Ruminska A; Jin SY; Zheng XL; van den Biggelaar M; ten Brinke A; Meijer AB; Voorberg J
    Blood; 2012 May; 119(22):5294-300. PubMed ID: 22498747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of CD40/CD40 ligand interactions prevents induction of factor VIII inhibitors in hemophilic mice but does not induce lasting immune tolerance.
    Reipert BM; Sasgary M; Ahmad RU; Auer W; Turecek PL; Schwarz HP
    Thromb Haemost; 2001 Dec; 86(6):1345-52. PubMed ID: 11776297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen-specific immunotherapy with apitopes suppresses generation of FVIII inhibitor antibodies in HLA-transgenic mice.
    Pletinckx K; Nicolson KS; Streeter HB; Sanderson WJ; Schurgers E; Jansson L; Wraith DC
    Blood Adv; 2022 Apr; 6(7):2069-2080. PubMed ID: 34529764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of factor VIII-specific unresponsiveness by intrathymic factor VIII injection in murine hemophilia A.
    Madoiwa S; Yamauchi T; Kobayashi E; Hakamata Y; Dokai M; Makino N; Kashiwakura Y; Ishiwata A; Ohmori T; Mimuro J; Sakata Y
    J Thromb Haemost; 2009 May; 7(5):811-24. PubMed ID: 19220731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-C1 domain antibodies that accelerate factor VIII clearance contribute to antibody pathogenicity in a murine hemophilia A model.
    Batsuli G; Ito J; Mercer R; Baldwin WH; Cox C; Parker ET; Healey JF; Lollar P; Meeks SL
    J Thromb Haemost; 2018 Sep; 16(9):1779-1788. PubMed ID: 29981270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cells from hemophilia A subjects recognize the same HLA-restricted FVIII epitope with a narrow TCR repertoire.
    Ettinger RA; Paz P; James EA; Gunasekera D; Aswad F; Thompson AR; Matthews DC; Pratt KP
    Blood; 2016 Oct; 128(16):2043-2054. PubMed ID: 27471234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lineages of human T-cell clones, including T helper 17/T helper 1 cells, isolated at different stages of anti-factor VIII immune responses.
    Ettinger RA; James EA; Kwok WW; Thompson AR; Pratt KP
    Blood; 2009 Aug; 114(7):1423-8. PubMed ID: 19549986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.